# Phathom Pharmaceuticals, Inc.: Form 8-K, filed Oct 29, 2026

- Company: [Phathom Pharmaceuticals, Inc.](/companies/phat.md) (CIK 1783183)
- Form: 8-K
- Filed: 2026-10-29
- Accepted by EDGAR: Oct 29, 2026, 07:05 ET
- Period: 2026-10-29
- Accession: 0001193125-26-436959
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1783183/000119312526436959/d180192d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1783183/000119312526436959/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1783183/000119312526436959/d180192d8k.htm

Filed Oct 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-436959. Last ingested by Listed: Nov 11, 2026, 03:04 ET. No prices; not investment advice.
